California State Legislature recognizes Grifols for its Decennial Anniversary in California

California State Legislature recognizes Grifols for its Decennial Anniversary
                                in California

PR Newswire

LOS ANGELES, Aug. 12, 2013

LOS ANGELES, Aug. 12, 2013 /PRNewswire/ --Today Grifols was honored at the
California State Legislature by state Senator Kevin de Leon(D-Los Angeles)
and Assembly Member Jimmy Gomez (D- East Los Angeles) marking the 10^th
Anniversary of the Company's establishment of its U.S. headquarters in Los
Angeles, and a decade of conducting business in California and improving the
health and well-being of people around the world.

(Logo: http://photos.prnewswire.com/prnh/20110304/PH59473LOGO )

Grifols, a global healthcare company based in Barcelona, Spain, produces
life-saving plasma medicines out of human plasma for people with rare, chronic
and life-threatening conditions. California is one of Grifols' largest and
most important business hubs with Los Angeles housing the company's U.S.
headquarters and its 350,000 square-foot state-of-the-art manufacturing
facility. Grifols acquired the El Sereno facility in East Los Angeles in
2003. Since then, it has completed a large scale $135 million dollar capital
investment project that includes the construction of a new 95,000 square foot,
intravenous immune globulin (IVIG) production facility.

"Grifols is proud of the Company's significant investments in the state,
reflecting our strong commitment to California and to meeting the needs
patients who rely on life-saving plasma therapies well into the future,"
commented Greg Rich, CEO of Grifols Inc.

"Grifols is pleased to employ over 1,200 Californians in high-quality skilled
jobs and continues to foster a thriving workforce in Los Angeles and across
the state," said Willie Zuniga, President of Grifols Biologicals Inc., who has
also developed strong partnerships with Los Angeles Trade Technical College,
California State University, Los Angeles, and the Wilshire-Metro WorkSource
Center to promote education, job training and skills development for area
residents.

In addition to the Los Angeles site, Grifols operates a 140,000 square-foot
climate-controlled plasma warehouse and final packaging center in the City of
Industry and owns and operates six plasma donation centers from San Diego to
Bakersfield, where Californians donate their plasma for the production of
life-saving medicines.

About Grifols

Grifols is a global healthcare company with a 70-year legacy of improving
people's health and well-being through the development of life-saving plasma
medicines, hospital pharmacy products, and diagnostic technology for clinical
use.

As a leading producer of plasma medicines, Grifols has a presence in more than
100 countries and is the world leader in plasma collection, with 150 plasma
donation centres across the US. Grifols is committed to increasing patient
access to its life-saving plasma medicines through significant manufacturing
expansions and the development of new therapeutic applications of plasma
proteins. The company is headquartered in Barcelona, Spain, and employs more
than 11,000 people worldwide.

In 2012, Grifols' sales exceeded 2,620 million euros. The company's class A
shares are listed on the Spanish Stock Exchange, where they form part of the
Ibex-35 (MCE:GRF). Its non-voting class B shares are listed on the Mercado
Continuo (MCE:GRF.P) and on the US NASDAQ via ADRs (NASDAQ: GRFS). For more
information, visitwww.grifols.com.

SOURCE Grifols

Website: http://www.grifols.com
Contact: Punkaj Amin, 919-316-6664